Image from Google Jackets

Normal view MARC view ISBD view

Benefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO / Stephanie Nebehay

By:

Nebehay, Stephanie

Subject(s):

Online resources:

Click here to access online

Summary: https://news.abs-cbn.com/overseas/03/18/21/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who

Hello from Record Display Customizations!

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Cover image	Item type	Current library	Home library	Collection	Shelving location	Call number	Materials specified	Vol info	URL	Copy number	Status	Notes	Date due	Barcode	Item holds	Item hold queue priority	Course reserves
	News Clippings	DOH Central Library Electronic Resource Section				031821-003 (Browse shelf(Opens below))					Available			D0001NC031821-003

Browsing DOH Central Library shelves,Shelving location: Electronic Resource Section Close shelf browser (Hides shelf browser)

Previous	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	Next
Previous	031621-025 DOH-7 official to Boholanos: 'Choose to be vaccinated' /	031821-001 Concepcion: 1 million Covaxin doses offered to private sector /	031821-002 J&J jab effective in countries with variants: WHO experts	031821-003 Benefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO /	031821-004 Aktibong kaso ng COVID-19 sa PTV, bumaba na sa 19 /	031821-005 COVID-19 cases hit peak 2020 level /	031821-006 Duque: FDA may revise Sinovac jab advisory if data backs vaccination for seniors /	Next

https://news.abs-cbn.com/overseas/03/18/21/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who

There are no comments on this title.

to post a comment.